SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insite Vision Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Mammon who wrote (892)11/24/1998 11:28:00 AM
From: bob zagorin  Read Replies (1) | Respond to of 1060
 
Vision Care Industry Profiled for Institutional Investors

WESTPORT, Conn.--(BUSINESS WIRE)--Nov. 24, 1998--An analysis of the prospects for the vision care market is the highlight of "Investments in Sight," a special section in the December 1998 issue of Buyside, a magazine for institutional investors.

Investments in Sight reports on the forces that will drive the continued growth of the industry: demographics, fashion, developing technology, consolidation and more. This article is followed by corporate profiles that discuss how individual companies are exploiting vision care market dynamics to achieve growth and create shareholder value.

The market overview and corporate profiles also appear on the OptiStock.com website (http://www.optistock.com). OptiStock.com and its free weekly e-mail newsletter, OptiStock News, provide investors with information on the vision care market including weekly, quarterly and year-to-date stock performance; current news and market overviews; analyst recommendations and interviews; stock quotes; and the OptiStock Index, a month-by-month composite index of vision care stocks.

OptiStock follows more than 70 companies involved in the vision care field, including 1-800 Contacts (NASDAQ:CTAC), Akorn (NASDAQ:AKRN), Allergan (NYSE:AGN), Alpha Bytes (NASDAQ:ABYT), Atlantic Pharmaceuticals (NASDAQ:ATLC), Autonomous Technologies (NASDAQ:ATCI), Bacou (NASDAQ:BAU), Bausch & Lomb (NYSE:BOL), Bolle (NASDAQ:BEYE), Cole National (NYSE:CNJ), The Cooper Companies (NYSE:COO), Corning (NYSE:GLW), Coronado Industries (NASDAQ:CDIK), DeRigo (NYSE:DER), Ergovision (NASDAQ:ERGV), Escalon Medical (NASDAQ:ESMC), Eyemakers (NASDAQ:EYEM), First American Health (NASDAQ:FAHC), Gargoyles (NASDAQ:GOYL), Gerber Scientific (NYSE:GRB), Gimbel Vision (ASE:GBV), InSite Vision (AMEX:ISV), Iridex (NASDAQ:IRIX), KeraVision (NASDAQ:KERA), LCA-Vision (NASDAQ:LCAV), LaserSight (NASDAQ:LASE), Laser Vision Centers (NASDAQ:LVCI), Luxottica (NYSE:LUX), Medical Technology & Innovations (NASDAQ:MTEN), Medjet (NASDAQ:MDJT), MedNet (TSE:MDT), Mentor (NASDAQ:MNTR), Miravant (NASDAQ:MRVT), National Vision (NASDAQ:NVAL), Oakley (NYSE:OO), Ocular Sciences (NASDAQ:OCLR), Omega Health (NASDAQ:OHSI), Paradigm Medical (NASDAQ:PMED), Pharmos (NASDAQ:PARS), Physicians Resource Group (NASDAQ:PRG), Premier Laser (NASDAQ:PLSIA), QLT PhotoTherapeutics (NASDAQ:QLTIF), Serengeti Eyewear (NASDAQ:SOLR), Sight Resource (NASDAQ:VISN), Signature Eyewear (NASDAQ:SEYE), Sola (NYSE:SOL), Staar Surgical (NASDAQ:STAA), Sterling Vision (NASDAQ:ISEE), Summit Technology (NASDAQ:BEAM), Sunglass Hut (NASDAQ:RAYS), Sunrise Technologies (NASDAQ:SNRS), TLC The Laser Center (NASDAQ:LZRCF), UltraVision (ASE:UVC), U.S. Vision (NASDAQ:USVI), Vision Twenty-One (NASDAQ:EYES), Visx (NASDAQ:VISX), and Wesley Jessen (NASDAQ:WJCO).

Buyside reaches 30,000 institutional investors and is published by Financial Communications Company, Inc. Investments in Sight, OptiStock.com and OptiStock News are publications of Access Media, LLC.

CONTACT:

Ron Walker

Access Media, LLC

(203)222-0139 voice

(203)227-8253 fax